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Background: Although catheter ablation of hemodynamically unstable ventricular tachycardia (VT) is possible with mechanical circulatory 
support (MCS), little is known regarding the relative efficacy of different supporting devices for such procedures. This study compared the efficacy of 
hemodynamic supports using various types of MCS for catheter ablation of unstable VT.
methods: Over a 3 year period since 2009, 16 consecutive patients (aged 63 ± 11 years with left ventricular ejection fraction of 20 ± 9%) who 
underwent ablation of hemodynamically unstable VT were included in this study. Hemodynamic support included percutaneous (Impella® 2.5, n=5), 
implantable left ventricular assist devices (LVADs, n=6), and peripheral cardiopulmonary bypass (CPB, n=5).
results: Except for 2 Impella cases, hemodynamic support was adequate (with consistent mean arterial pressure of >60 mmHg), allowing sufficient 
activation mapping for ablation. In the Impella and CPB groups, the mean time under hemodynamic support was 185 ± 86 minutes, and the time 
in VT was 78 ± 36 minutes. Clinical VT could be terminated at least once by ablation in all patients except 1 with Impella due to hemodynamic 
instability. Peri-procedural complication included hemolysis in 1 patient with Impella and surgical intervention was needed for percutaneous Impella 
placement problems in another 2 patients. The median number of appropriately delivered defibrillator therapy was significantly decreased from 6 in 
the month before VT ablation to 0 in the month following ablation (p=0.001).
conclusion: Our data suggest that peripheral CPB and implantable LVAD provide adequate hemodynamic support for successful ablation of 
unstable VT. Impella® 2.5, on the other hand, was associated with increased risk of complication, and may not provide sufficient hemodynamic 
support in some unstable VT patients.
